Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
greater disease » greater decrease (Expand Search), related disease (Expand Search), greater sense (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), nn decrease (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
greater disease » greater decrease (Expand Search), related disease (Expand Search), greater sense (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), nn decrease (Expand Search)
-
981
Minimal data set.
Published 2024“…In contrast, with a negative Soret coefficient, the growth rate of the spherical crystals increases as the coefficient decreases, and the solute concentration near the interface decreases. …”
-
982
-
983
Image1_The immunological and prognostic significance of the diabetes mellitus-related gene WFS1 in endometrial cancer.tif
Published 2024“…First, we identified WFS1 as the target gene and obtained EC data from the TCGA database. …”
-
984
Table2_The immunological and prognostic significance of the diabetes mellitus-related gene WFS1 in endometrial cancer.xlsx
Published 2024“…First, we identified WFS1 as the target gene and obtained EC data from the TCGA database. …”
-
985
Table3_The immunological and prognostic significance of the diabetes mellitus-related gene WFS1 in endometrial cancer.docx
Published 2024“…First, we identified WFS1 as the target gene and obtained EC data from the TCGA database. …”
-
986
Table1_The immunological and prognostic significance of the diabetes mellitus-related gene WFS1 in endometrial cancer.xlsx
Published 2024“…First, we identified WFS1 as the target gene and obtained EC data from the TCGA database. …”
-
987
-
988
-
989
-
990
-
991
-
992
-
993
-
994
-
995
Average % peptides counts for different classes of proteins at different germination time points and significant p-value indicated as compared to soaked sample (*p< 0.05, **p<0.01, ***p<0.001) for brown non-trypsinised with shades of green showing increase and red showing decrease with respect to soaked.
Published 2024“…<p>Average % peptides counts for different classes of proteins at different germination time points and significant p-value indicated as compared to soaked sample (*p< 0.05, **p<0.01, ***p<0.001) for brown non-trypsinised with shades of green showing increase and red showing decrease with respect to soaked.…”
-
996
Average of % peptides counts for different classes of proteins at different germination time points and significant p-value indicated as compared to soaked sample (*p< 0.05, **p<0.01, ***p<0.001) for garbanzo non-trypsinised with shades of green showing increase and red showing decrease with respect to soaked.
Published 2024“…<p>Average of % peptides counts for different classes of proteins at different germination time points and significant p-value indicated as compared to soaked sample (*p< 0.05, **p<0.01, ***p<0.001) for garbanzo non-trypsinised with shades of green showing increase and red showing decrease with respect to soaked.…”
-
997
-
998
Characterization of miRNA expression profiles and their potential targets upon Bz and Bz + PTX therapy in chronically infected mice. Relative expression was expressed as fold change (2<sup>-ΔΔCt</sup>). miRNAs with a fold change greater than 1.3 in the vehicle group and at the 0.75–1.3 range (orange striped area) in the Bz and Bz + PTX therapy groups were considered to have a restored expression. They were selected for further analysis on IPA software. (A) The expression of miRNAs was altered in the infected group and an expression was restored after Bz therapy. (B) Top canonical activated pathways in the infected group with a restored expression upon Bz therapy. (C) Diseases and disorders pathway analysis. (D) The expression of miRNAs was altered in the infected group and restored upon Bz + PTX therapy. (E) Top canonical activated pathways in the infected group with a restored expression upon Bz therapy. (F) Diseases and disorders pathway analysis. Significant intervals
Published 2025“…(E) Top canonical activated pathways in the infected group with a restored expression upon Bz therapy. (F) Diseases and disorders pathway analysis. Significant intervals</p>…”
-
999
-
1000